Sachs Benjamin D, Baillie George S, McCall Julianne R, Passino Melissa A, Schachtrup Christian, Wallace Derek A, Dunlop Allan J, MacKenzie Kirsty F, Klussmann Enno, Lynch Martin J, Sikorski Shoana L, Nuriel Tal, Tsigelny Igor, Zhang Jin, Houslay Miles D, Chao Moses V, Akassoglou Katerina
Department of Pharmacology, University of California, San Diego, La Jolla, CA 92093, USA.
J Cell Biol. 2007 Jun 18;177(6):1119-32. doi: 10.1083/jcb.200701040.
Clearance of fibrin through proteolytic degradation is a critical step of matrix remodeling that contributes to tissue repair in a variety of pathological conditions, such as stroke, atherosclerosis, and pulmonary disease. However, the molecular mechanisms that regulate fibrin deposition are not known. Here, we report that the p75 neurotrophin receptor (p75(NTR)), a TNF receptor superfamily member up-regulated after tissue injury, blocks fibrinolysis by down-regulating the serine protease, tissue plasminogen activator (tPA), and up-regulating plasminogen activator inhibitor-1 (PAI-1). We have discovered a new mechanism in which phosphodiesterase PDE4A4/5 interacts with p75(NTR) to enhance cAMP degradation. The p75(NTR)-dependent down-regulation of cAMP results in a decrease in extracellular proteolytic activity. This mechanism is supported in vivo in p75(NTR)-deficient mice, which show increased proteolysis after sciatic nerve injury and lung fibrosis. Our results reveal a novel pathogenic mechanism by which p75(NTR) regulates degradation of cAMP and perpetuates scar formation after injury.
通过蛋白水解降解清除纤维蛋白是基质重塑的关键步骤,有助于在多种病理状况下进行组织修复,如中风、动脉粥样硬化和肺部疾病。然而,调节纤维蛋白沉积的分子机制尚不清楚。在此,我们报告称,p75神经营养因子受体(p75(NTR))是组织损伤后上调的肿瘤坏死因子受体超家族成员,它通过下调丝氨酸蛋白酶组织型纤溶酶原激活物(tPA)和上调纤溶酶原激活物抑制剂-1(PAI-1)来阻断纤维蛋白溶解。我们发现了一种新机制,其中磷酸二酯酶PDE4A4/5与p75(NTR)相互作用以增强环磷酸腺苷(cAMP)降解。p75(NTR)依赖的cAMP下调导致细胞外蛋白水解活性降低。在p75(NTR)缺陷小鼠体内也证实了这一机制,这些小鼠在坐骨神经损伤和肺纤维化后显示出蛋白水解增加。我们的结果揭示了一种新的致病机制,即p75(NTR)调节cAMP降解并在损伤后持续形成瘢痕。